Thynk Capital logo

Thynk Capital

North America, Nevada, United States, Las Vegas

Description

Historical Investment Performance in Top 1% of Venture Funds. Primary focus on Longevity and defeating Diseases of Aging.

Investor Profile

Thynk Capital has made 16 investments, with 0 in the past 12 months and 6% as lead.

Stage Focus

  • Convertible Note (31%)
  • Series A (31%)
  • Seed (25%)
  • Post Ipo Equity (6%)
  • Series Unknown (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Manufacturing
  • Medical Device
  • Automotive
  • Electric Vehicle
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Thynk Capital frequently co-invest with?

Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 1
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
SENS Foundation
North America, California, United States, Mountain View
Co-Investments: 1
Bioverge
North America, California, United States, San Francisco
Co-Investments: 1
GoldenSand Capital
Asia, Beijing, China, Beijing
Co-Investments: 1

Which angels does Thynk Capital often collaborate with?

JM
Europe, Isle of Man
Shared Deals: 1

What are some of recent deals done by Thynk Capital?

IMX

Chicago, Illinois, United States

IMX Health is the first financial futures exchange for the healthcare industry.

Financial ServicesHealth Care
SeedAug 20, 2021
iviva medical

Beverly, Massachusetts, United States

IVIVA Medical was founded with the goal of developing autologous tissue constructs as a solution to end-state kidney disease (ESKD).

Construction
SeedMar 5, 2021
Viscient Biosciences

San Diego, California, United States

Viscient Biosciences is a biotechnology company working at the intersection of human 3D tissue technology and multi-omics analysis.

BiotechnologyHealth CareLife Science
SeedMay 30, 2019
Repair Biotechnologies

Syracuse, New York, United States

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.

BiotechnologyHealth CareMedical
SeedMay 7, 2019
Amount Raised: $2,150,000
X-Vax Technology

Jupiter, Florida, United States

X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.

BiotechnologyHealth CareMedical
Series AApr 5, 2019
Repair Biotechnologies

Syracuse, New York, United States

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.

BiotechnologyHealth CareMedical
Convertible NoteApr 1, 2019
Elicio Therapeutics

Cambridge, Massachusetts, United States

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series UnknownNov 6, 2018
KitoTech Medical

Seattle, Washington, United States

KitoTech Medical is a medical device company developing and commercializing products for wound closure and wound care.

BiotechnologyHealth CareManufacturingMedical Device
Convertible NoteJun 25, 2018
Marina Biotech

City Of Industry, California, United States

Patient Centric Care for Hypertension and Pain

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityMar 22, 2018
Elevian

Allston, Massachusetts, United States

Elevian develops medicines that restore youthful regenerative capacity with the potential to treat and prevent many age-related diseases.

BiopharmaBiotechnologyTherapeutics
Convertible NoteFeb 20, 2018
Amount Raised: $2,900,000